Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

Principal Investigator: Bouchard, Elizabeth G

A phase Ib/2 study of IMGN632 as monotherapy or combination with venetoclax and/or azacitidine for patients with CD123+ AML

Principal Investigator: Wang, Eunice S

Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

Principal Investigator: Abad, Ajay P

Perioperative Analysis of Binimetinib and Palbociclib in RAS-driven tumors

Principal Investigator: Fountzilas, Christos

A Phase I/II Study of AKR1C3-Activated Prodrug Obi-3424 (Obi-3424) in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)/T-Cell Lymphoblastic Lymphoma (T-LBL)

Principal Investigator: Wang, Eunice S

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan versus Treatment of Physician's Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer

Principal Investigator: George, Saby

(ANHL1931) A Randomized Phase 3 trial of Nivolumab (NSC#748726 IND#125462) in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

Principal Investigator: Twist, Clare J

(AAML18P1) Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

Principal Investigator: Twist, Clare J

A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer

Principal Investigator: Singh, Anurag K

BMT CTN 1904 Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases

Principal Investigator: Bambach, Barbara J

(HCRN ESO17-325) A Phase II Study Evaluating Safety and Efficacy of Niraparib in Patients with Previously Treated Homologous Recombination (HR) Defective or Loss of Heterozygosity (LOH) high Metastatic
Esophageal/Gastroesophageal Junction/Proximal…

Principal Investigator: Fountzilas, Christos

A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer

Principal Investigator: Singh, Anurag K

A Phase 2 Randomized Study with a non-Randomized Cohort: Assessing Single-fraction SBRT versus STandard PalliativE Radiation In Patients with Metastatic Disease (ASTEROID)

Principal Investigator: Singh, Anurag K

A Phase 1 Study of Oral LY3410738 in Patients with Advanced Hematologic Malignancies with IDH1 or IDH2 Mutations

Principal Investigator: Wang, Eunice S

Influence of Yoga on Cancer-Related Stress in Cancer Survivors

Principal Investigator: Glaser, Kathryn M

A Phase 1/2 Study of REGN5678 (anti-PSMAxCD28) with Cemiplimab (anti-PD-1) in Patients with Metastatic Castration-resistant Prostate Cancer (R5678-ONC-1879)

Principal Investigator: Chatta, Gurkamal S

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K; Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis

Principal Investigator: Wang, Eunice S

A Phase II Study of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia

Principal Investigator: Przespolewski, Amanda C

Investigating the correlation between the Brain and Pelvic Floor Muscle Activity of Patients Undergoing Robot-Assisted radical Prostatectomy

Principal Investigator: Guru, Khurshid

The PISCES Study: A Multicenter Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid (tavo, pIL-12) plus Electroporation in Combination with Intravenous Pembrolizumab in Patients with Stage III/IV Melanoma who are Progressing on either…

Principal Investigator: Puzanov, Igor

Long-Term Follow-Up Protocol for Subjects Treated with Gene-Modified T Cells

Principal Investigator: Hernandez-Ilizaliturri, Francisco J

Double-arm, Randomized Study of Botulinum Toxin Injection as a Pyloric Drainage Procedure for Minimally Invasive Esophagectomy (Phase II)

Principal Investigator: Kukar, Moshim

Phase 1/1b Trial of Talazoparib and Gemtuzumab ozogamicin in Adult Patients with Relapsed and/or Refractory Acute Myeloid Leukemia

Principal Investigator: Wang, Eunice S

A PHASE 1b/2 RANDOMIZED STUDY OF AVB-S6-500 PLUS NAB-PACLITAXEL AND GEMCITABINE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC ADENOCARCINOMA

Principal Investigator: Fountzilas, Christos

A PHASE 2 STUDY OF BA3011 ALONE AND IN COMBINATION WITH NIVOLUMAB IN ADULT PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER WHO HAD PRIOR DISEASE PROGRESSION ON A PD-1/L1, EGFR, OR ALK INHIBITOR

Principal Investigator: Dy, Grace K